Showing 2311-2320 of 8978 results for "".
Exosomes 101
https://practicaldermatology.com/conferences/scale-2023/exosomes-101/20192/Exosomes are today's hottest skincare ingredient, and Glynis Ablon, MD, gives viewers the scoop on how and when to use them.Skin Cancer Perceptions, Cimzia for Psoriasis, Eczema and CV Risk
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-skin-cancer-perceptions-cimzia-for-psoriasis-eczema-and-cv-risk/18301/A new national survey, Skin Cancer In America 2018, conducted by Health Union, explores perceptions of patients with skin cancer. Cimzia (certolizumab pegol, UCB) has received FDA approval for treatment of adults with moderate to severe plaque psoriasis. Cimzia is the first Fc-free, PEGylated anti TRadiesse Plus Launches, AAD Convenes, NPF Registry Begins
https://practicaldermatology.com/topics/psoriasis/dermwiretv-radiesse-plus-launches-aad-convenes-npf-registry-begins--epesurag/18939/In this edition of DermWireTV: Merz Aesthetics launches Radiesse Plus with lidocaine for the treatment of facial wrinkles and folds and the National Psoriasis Foundation (NPF) launches new patient registry focused on patient safety. Plus, updates from the annual meeting of the American Academy of DeConnective Tissue Disorders Update 2025: Dr. Vleugels
https://reachmd.com/programs/practical-dermatology/connective-tissue-disorders-update-2025-dr-vleugels/32673/Ruth Ann Vleugels, MD, PhD, recaps her presentation, "Connective Tissue Disorders Update 2025" at Maui Derm 2025. Dr. Vleugels discussed a new therapeutic for systemic lupus, a new FDA-approved option for dermatomyositis, JAK inhibitors, and more."Best Practices in the Treatment of Acne" Drs. Harper and Stein-Gold
https://practicaldermatology.com/youngmd-connect/ymdc-workshops/best-practices-in-the-treatment-of-acne-drs-harper-and-stein-gold/24543/Expert dermatologists Drs. Linda Stein Gold and Julie Harper share their insights on treating acne across all severities. Join their discussion with YoungMD Connect members for valuable experiences and practice pearls. To access the full video and more, become a YoungMD Connect member for free 90-daA Case Presentation of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37154/Alina Bridges, DO, Director of Dermatopathology & Associate Professor in the Department of Dermatology and Anatomic Pathology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, presents a case study involving a patient who had been on multiple treatments to present prurituJournal Club: Efficacy of Systemics After Discontinuation
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-efficacy-of-systemics-after-discontinuation/32829/Practical Dermatology chief medical editor Neal Bhatia, MD, FAAD, is joined by Naiem T. Issa, MD, PhD, to discuss an article Dr. Issa authored reviewing published literature on the efficacy of biologics as monotherapy for atopic dermatitis following discontinuation. Issa NT, Abdin R, et al.Journal Club: Colloidal Oat for Prevention and Treatment
https://reachmd.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-colloidal-oat-for-prevention-and-treatment/32407/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Editorial Board member Lawrence Eichenfield, MD, FAAD, discuss a study demonstrating the benefits of oat for infant skincare, especially for the treatment and mitigation of atopic dermatitis.Evaluating GEP Test Options
https://reachmd.com/programs/practical-dermatology/evaluating-gep-test-options/35600/David Cotter, MD, a board-certified dermatologist, discusses what he looks for in a gene expression profile (GEP) test, including the types of clinical evidence that are most important.GEP Testing for Cutaneous Squamous Cell Carcinoma
https://practicaldermatology.com/series/updates-in-skin-cancer/gep-testing-for-cutaneous-squamous-cell-carcinoma/35599/Emily Ruiz, MD, MPH, FAAD, director of the High-Risk Cancer Clinic at Dana-Farber Cancer Institute, discusses utilizing gene expression profiling (GEP) to risk stratify tumors in cutaneous squamous cell carcinoma patients.